ScienceNot yet confirmed elsewhere1 publisher2 min readPublished
Hollow silica nanostructures let low-intensity ultrasound stimulate mouse brains for over nine weeks
Hong Kong Polytechnic University team reports hollow silica nanostructures that kept responding to ultrasound in mouse brains for over nine weeks. Earlier nanoparticle approaches lacked that durability. The evidence so far comes from mice.
The Scientist · Science desk
Ultrasound alone: millimeter-to-centimeter resolution. Earlier nanoparticles: unstable in vivo, limiting chronic use. Deep brain stimulation: surgery to place electrodes. Nanostructures: lasted over nine weeks in mice, responsive to ultrasound. With nanostructures: precise, durable stimulation.
- constraint Transcranial ultrasound alone Resolution typically limited to millimeter or centimeter scales; small neuron groups hard to select, claim 7
- constraint Earlier nanoparticle methods Improved localization, but in vivo instability limited chronic use, claim 8
- cost Deep brain stimulation Involves surgery to place electrodes deep inside the brain, claim 10
- capability Hollow silica nanostructures Persisted in the mouse brain more than nine weeks while remaining responsive to ultrasound, claim 2
- capability Ultrasound with nanostructures Made ultrasound neuromodulation spatially precise and durable, the summary says, claim 12
| Who | How | Kind | Claim |
|---|---|---|---|
| Transcranial ultrasound alone | Resolution typically limited to millimeter or centimeter scales; small neuron groups hard to select | constraint | 7 |
| Earlier nanoparticle methods | Improved localization, but in vivo instability limited chronic use | constraint | 8 |
| Deep brain stimulation | Involves surgery to place electrodes deep inside the brain | cost | 10 |
| Hollow silica nanostructures | Persisted in the mouse brain more than nine weeks while remaining responsive to ultrasound | capability | 2 |
| Ultrasound with nanostructures | Made ultrasound neuromodulation spatially precise and durable, the summary says | capability | 12 |
What happened
- The same nanostructures allowed repeated stimulation of the motor cortex, striatum, ventral tegmental area and subthalamic nucleus without genetic modification or repeated intracranial administration.
- Ultrasound applied to the nanostructure-targeted subthalamic nucleus increased dopamine signaling in circuits linked to movement.
- A second Parkinson's model showed similar benefits, and the summary says the method may achieve some DBS-like effects without implanted electrodes.
Why it matters
- constraint The spatial precision comes from the nanostructures [c14], and the ultrasound beam alone is only millimeter or centimeter scale [c7]. Where the particles sit decides which neurons respond, so placement is the quantity a larger brain would have to control.
- cost The summary says 'without repeated intracranial administration' [c3]. We read that as at least one administration, so 'minimally invasive' here means a single delivery of nanomaterial into the brain that then persists for weeks [c2].
- decision The summary sets up levodopa's fading consistency [c9] and the surgery DBS requires [c10] as the problems, then closes by saying the approach 'may complement or, in some cases, reduce reliance on conventional invasive neuromodulation strategies' [c13]. Levodopa is only background there. The first test that would matter is against DBS in the same model.
Conventional transcranial ultrasound penetrates deeply and can be delivered without surgery, but its spatial resolution is typically millimeter or centimeter scale [7]. Earlier nanoparticle- and nanobubble-assisted methods improved localization, yet their instability in vivo limited chronic use [8]. The hollow silica structures go after that second problem: they stayed responsive for more than nine weeks [2], and the summary credits the stable, sonoresponsive nanostructures with the spatial precision [12].
Nine weeks is a minimum, since the source's wording is "more than nine weeks" [2]. Parkinson's is mainly linked to the gradual loss of dopamine-producing nerve cells [13], and we'd expect a human version of this approach to be judged over a far longer course.
Two measurements carry the Parkinson's claim. Ultrasound on the targeted subthalamic nucleus increased dopamine signaling, and the summary's own verb for what that shows is "suggesting" [4]. Separately, treated mice kept more dopamine-related neurons [5]. A rise in signaling during stimulation and better neuron survival after treatment are different readouts, and the first does not explain the second by itself.
The summary does not say how large the dopamine rise was, or in how many animals, and it gives no group sizes, effect sizes, or control arms such as nanostructures without ultrasound and ultrasound without nanostructures. The paper is Hou et al. in Nature Communications [11], from the team led by Lei Sun [1]. The write-up's own label for it is "a compelling proof of concept" [14].
What to watch
- The full Nature Communications paper: group sizes, effect sizes, and control arms with ultrasound alone and nanostructures alone.
- A head-to-head test of nanostructure-assisted ultrasound against deep brain stimulation in the same Parkinson's model.
- Data on how the nanostructures reach the target and how long they stay responsive beyond nine weeks.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence45
- Adoption
- Insufficient
- Hype gap+20
- Incentives
- Insufficient
- Confidence50
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Lei Sun, a professor in the Department of Biomedical Engineering and Sports Technology at The Hong Kong Polytechnic University, and his team combined low-intensity ultrasound with engineered hollow silica nanostructures (HSN) to achieve chronic, localized brain stimulation in mice, as well as therapeutic benefit in Parkinson's disease models.
- [2]
The HSN persisted in the mouse brain for more than nine weeks while remaining functionally responsive to ultrasound.
- [3]
The nanostructures enabled repeated stimulation of the motor cortex, striatum, ventral tegmental area (VTA) and subthalamic nucleus (STN) without genetic modification and without repeated intracranial administration.
- [4]
Ultrasound stimulation of the HSN-targeted STN increased dopamine signaling, suggesting that the approach activated pathways affected in Parkinson's disease.
- [5]
Treated mice also showed better preservation of dopamine-related neurons.
- [6]
Similar benefits were seen in a second Parkinson's model, indicating that the ultrasound-based method may achieve some DBS-like effects without implanted electrodes.
- [7]
Conventional transcranial ultrasound penetrates deeply and can be delivered noninvasively, but its spatial resolution is typically limited to millimeter or centimeter scales, making selective activation of small neuronal populations difficult.
- [8]
Earlier nanoparticle- or nanobubble-assisted approaches improved localization, but their in vivo instability limited usefulness for chronic applications.
- [9]
Medicines such as levodopa can improve symptoms, especially in the earlier stages, but their benefit may become less consistent over time.
- [10]
Deep brain stimulation (DBS) involves surgery to place electrodes deep inside the brain.
- [11]
The research, by Xuandi Hou et al., is titled 'Sono-mechanical nanostructures-enabled sustained precise ultrasound brain stimulation' and is published in Nature Communications (2026), DOI 10.1038/s41467-026-69710-8.
- [12]
The principal advancement is the demonstration that ultrasound neuromodulation can be made both spatially precise and durable through the use of stable, sonoresponsive nanostructures.
- [13]
Parkinson's disease is mainly linked to the gradual loss of dopamine-producing nerve cells.
- [14]
The summary says: 'This research provides a compelling proof of concept for chronic, localized and minimally invasive neuromodulation using ultrasound and hollow silica nanostructures.'
- [15]
The summary says the work suggests a future in which engineered nanomaterials and focused acoustic energy 'may complement or, in some cases, reduce reliance on conventional invasive neuromodulation strategies.'
Sources
1 independent publisher whose own reporting we read for this story.
- phys.orgNanostructure-assisted ultrasound shows potential for Parkinson's treatment
1 article · October 12, 2026
Topics and entities
Follow any of these and your For You feed starts watching them — no settings page required.
Topics
- Nanomaterials in medicineFollow
- Parkinson's diseaseFollow
- Deep brain stimulationFollow
- Ultrasound neuromodulationFollow